Imcyse
PrivateLast Round
Series B
Extension
Feb 17, 2021
Total Funding Raised
$66.18M
Company Overview
Imcyse is a biotechnology company that develops active specific immunotherapies for the treatment and prevention of severe chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imcyse Comparables
Compare Imcyse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anokion | 88% | |
| COUR Pharmaceuticals | 86% | |
| Worg Pharmaceuticals | 82% | |
Imcyse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 17, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Debt | Jun 18, 2019 | ||||
| Grant | Jun 18, 2019 | ||||
| Series B | Jun 18, 2019 | ||||
Grant | Jun 6, 2017 |
Imcyse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B Extension, Series B |
| EQT Life Sciences | Series B Extension, Series B |
| Noshaq | Series B Extension, Series B |
| Epimede | Series B Extension, Series B |
| Société Régionale d'Investissement de Wallonie | Series B Extension, Series B |
| KU Leuven | Series B Extension, Series B |
| Pfizer | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2021
$26M round led by Pfizer
- Jun 18, 2019
$32M round led by EQT Life Sciences.
Imcyse Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imcyse's valuation, stock price, and market status.